A Phase 1b clinical trial testing pociredir in adults with sickle cell disease has completed enrollment of its high-dose ...
Beam Therapeutics Inc. trades at a relatively cheap valuation based on its multiples and potential in SCD. Learn more about ...
Results from a cross-sectional study revealed the gaps in knowledge related to fertility risks among patients with sickle cell disease (SCD), as well as shed light on patient perspectives on fertility ...
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the Saudi Food and Drug Authority (SFDA) granted Marketing Authorization for CASGEVY™ (exagamglogene ...
The Punch on MSN
SCD and the burden of care – Part 2
In Part 1 of SCD and the burden of care, we explored the emotional, physical, and financial weight that families carry while supporting a loved one living with sickle cell disease.We looked at how ...
Agios Pharmaceuticals (($AGIO)) announced an update on their ongoing clinical study. Agios Pharmaceuticals is conducting a Phase 2 clinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback